Showing results (541-550 of 2,688) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|November 18, 2022
Hidden sources of bias in diagnostic studies: the example of visceral leishmaniasis in east AfricaJohan van Griensven, Ermias Diro, Cedric P Yansouni
The Lancet. Infectious Diseases|February 9, 2023
Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFsIshmeala Rigby, Melina Michelen, Andrew Dagens, et al.
The Lancet. Infectious Diseases|November 24, 2025
Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling studyYing Zhang, Eric P F Chow, Lei Zhang, et al.
The Lancet. Infectious Diseases|November 22, 2025
Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort studyAnaïs Chosidow, Zoha Maakaroun-Vermesse, Vichita Ok, et al.
The Lancet. Infectious Diseases|November 14, 2025
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trialZacchaeus Anywaine, Jennifer Serwanga, Abu-Baker Mustapher Ggayi, et al.
The Lancet. Infectious Diseases|January 10, 2026
Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in LiberiaDavid A Wohl, Carwolo Pewu, Chanhwa Lee, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
The Lancet. Infectious Diseases|August 22, 2025
Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case-control studyOtavio T Ranzani, Felippe Lazar Neto, Lisany Krug Mareto, et al.
The Lancet. Infectious Diseases|November 7, 2025
Kyasanur Forest disease: an emerging arboviral threatNeha Pandey, Sunit K Singh
The Lancet. Infectious Diseases|October 30, 2025
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control studyRebecca Symes, Heather J Whitaker, Shazaad Ahmad, et al.
Pageof 269